| 前收市價 | 91.90 |
| 開市 | 91.83 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 91.09 - 92.24 |
| 52 週波幅 | 80.60 - 104.32 |
| 成交量 | |
| 平均成交量 | 1,382,514 |
| 市值 | 114.712B |
| Beta 值 (5 年，每月) | 0.45 |
| 市盈率 (最近 12 個月) | 25.43 |
| 每股盈利 (最近 12 個月) | 3.59 |
| 業績公佈日 | 2024年7月25日 |
| 遠期股息及收益率 | 3.76 (4.09%) |
| 除息日 | 2024年5月13日 |
| 1 年預測目標價 | 106.50 |
Insider MonkeyRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
ZacksRegeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
Motley Fool3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
It pays to develop novel medicines for life-threatening illnesses.
